Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum

NCT05376410 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT05376410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05376410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
Lead sponsor
Necmettin Erbakan University
Phase
Observational
Overall status
Unknown status
Start date
November 14, 2021
Completion date
July 1, 2022
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

placenta accreta, third trimester